Overnight switch from levetiracetam to brivaracetam. Safety and tolerability
Brivaracetam is a newer antiseizure medication than levetiracetam. It has a more selective action on the synaptic vesicle glycoprotein 2A binding site, and it seems to provide a more favorable neuropsychiatric profile. The aim of this study was to assess the safety and tolerability of an overnight s...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Elsevier
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/6d650cfbfe974b3c951bb5a60f53ba0b |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|